Skip to main content

letter

. 1988 Apr;41(4):476. doi: 10.1136/jcp.41.4.476

Unchanged concentrations of plasma fibronectin in Alzheimer's disease.

S I Rattan, L M Rasmussen, P Bjerring, P Bhatia, B F Clark

PMCID: PMC1141482 PMID: 3366937

476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Labat-Robert J., Robert L. Modifications of fibronectin in age-related diseases: diabetes and cancer. Arch Gerontol Geriatr. 1984 May;3(1):1–10. doi: 10.1016/0167-4943(84)90011-6. [DOI] [PubMed] [Google Scholar]
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
Selkoe D. J., Bell D. S., Podlisny M. B., Price D. L., Cork L. C. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science. 1987 Feb 20;235(4791):873–877. doi: 10.1126/science.3544219. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES